A Study to Evaluate the Efficacy and Safety of Ertugliflozin in Asian Participants With Type 2 Diabetes and Inadequate Glycemic Control on Metformin Monotherapy (MK-8835-012)
Clinical trial NCT02630706 · COMPLETED
Trial details
- NCT number
- NCT02630706
- Sponsor
- Merck Sharp & Dohme LLC
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2015-12-16
- Primary completion
- 2017-12-27
- Enrollment
- 506
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.